Ark. Carpenters Health & Welfare Fund v. Bayer AG
| Decision Date | 22 June 2009 |
| Docket Number | No. 08–1194.,08–1194. |
| Citation | 174 L.Ed.2d 553,557 U.S. 920,129 S.Ct. 2828 (Mem) |
| Parties | ARKANSAS CARPENTERS HEALTH AND WELFARE FUND, PAPER, A.F. OF L., et al., petitioners, v. BAYER AG and Bayer Corp., et al. |
| Court | U.S. Supreme Court |
Opinion
Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
To continue reading
Request your trial
1 cases
-
In re K–Dur Antitrust Litig.
...related to those confronted by the Second Circuit in Arkansas Carpenters. 544 F.3d 1323 (Fed.Cir.2008), cert. denied,––– U.S. ––––, 129 S.Ct. 2828, 174 L.Ed.2d 553 (2009).10 The Federal Circuit applied the scope of the patent test explicated in Tamoxifen and other cases, stating, “[t]he ess......
4 firm's commentaries
-
U.S. Supreme Court To Weigh In On Reverse Payment Deals
...cert. denied, 551 U.S. 1144 (2007); In re Ciprofloxacin Hydrochloride Antitrust Litig., 544 F.3d 1323 (Fed. Cir. 2008), cert. denied, 557 U.S. 920 (2009). In contrast, the Third Circuit views such agreements as closely resembling practices condemned as per se anticompetitive and treats them......
-
Supreme Court Rules On 'Reverse Payment' Settlements In Federal Trade Commission v. Actavis, Inc.
...cert. denied, 551 U.S. 1144 (2007); In re Ciprofloxacin Hydrochloride Antitrust Litig., 544 F.3d 1323 (Fed. Cir. 2008), cert. denied, 557 U.S. 920 (2009). The Court also rejected the rule previously used by the U.S. Court of Appeals for the Third Circuit, which treats reverse payment agreem......
-
Supreme Court Rules On 'Reverse Payment' Settlements In Federal Trade Commission v. Actavis, Inc.
...cert. denied, 551 U.S. 1144 (2007); In re Ciprofloxacin Hydrochloride Antitrust Litig., 544 F.3d 1323 (Fed. Cir. 2008), cert. denied, 557 U.S. 920 (2009). The Court also rejected the rule previously used by the U.S. Court of Appeals for the Third Circuit, which treats reverse payment agreem......
-
U.S. Supreme Court To Rule On 'Pay-for-Delay' Antitrust Issue
...cert. denied, 551 U.S. 1144 (2007); In re Ciprofloxacin Hydrochloride Antitrust Litigation, 544 F.3d 1323 (Fed. Cir. 2008), cert. denied, 557 U.S. 920 (2009). This split sets the stage for the Court's resolution in FTC v. Watson Pay-for-delay cases arise in settlements of patent infringemen......
1 books & journal articles
-
The Nexium Trial Pioneers Actavis' Activation: a Roundtable of Nexiums Counsel Reflect on Their Six-week Trial
...in the following cases: La. Wholesale Drug Co., Inc. v. Bayer AG, 562 U.S. 1280 (2011); Ark. Carpenters Health & Welfare Fund v. Bayer AG, 557 U.S. 920 (2009); Joblove v. Barr Labs, Inc., 551 U.S. 1144 (2007); F.T.C. v. Schering-Plough Corp., 548 U.S. 919 (2006); Valley Drug Co. v. Geneva P......